Cite
HARVARD Citation
Masetti, M. et al. (n.d.). KRAS and TP53 mutations are correlated with lower survival rate in resected pancreatic ductal adenocarcinoma. HPB. pp. S705-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Masetti, M. et al. (n.d.). KRAS and TP53 mutations are correlated with lower survival rate in resected pancreatic ductal adenocarcinoma. HPB. pp. S705-. [Online].